LRD renamed TRD
The Laboratory Research Division (LRD) has been renamed Translational Research Division (TRD). This change is consistent with the emphasis that EORTC scientific strategy places on translational research in our clinical trials.
Quality of Life (QOL) Fellowship
This past March 2009, Ms. Lily Claassens completed a two year fellowship in the QOL Department at EORTC Headquarters.
Report of Dr. Oscar Matzinger Emmanuel van der Schueren Fellow
Radiotherapy is a milestone in the treatment of cancers and requires complex equipment and techniques.
Results of the NOCI call for projects
The NOCI call at EGAM 2009 was conceived to advance EORTC scientific strategy and NOCI projects, in particular, and to foster interaction between the EORTC divisions and the EORTC groups.
Abstracts accepted for the 2009 ASCO Annual Meeting GalleryAbstracts accepted for the 2009 ASCO Annual Meeting
Brain Tumour Group, Gastrointestinal Tract Cancer Group, Gynecological Cancer Group, Head and Neck Cancer Group, Lung Cancer Group, Melanoma Group, News, Quality of Life Group, Radiation Oncology Group, Soft Tissue and Bone Sarcoma Group, Uncategorized
Abstracts accepted for the 2009 ASCO Annual Meeting
Eighteen EORTC abstracts have been accepted for presentation at the 2009 ASCO Annual meeting to be held 29 May to 2 June, 2009 in Orlando, Florida. A listing of these abstracts is given below.
The 31st Annual EORTC-PAMM Group Meeting, 28 – 30 January 2010
The 31st Annual EORTC-PAMM Group Meeting will be held 28 – 30 January 2010 in Toulouse, France.
NOCI call for projects at EGAM 2009
Translational research is an essential component of the EORTC Scientific Strategy and contributes to the distinction between studies comparing treatment regimes and academically driven studies asking biologically relevant questions.
EORTC Scientific Strategies and priorities
Although development of new and innovative therapies is critical for improving cancer care, the primary interests of the EORTC remain with clinical trials that investigate strategic therapeutic questions that will influence medical practice or will fundamentally improve th
EORTC Board Elections
The election of the new EORTC Board will take place on 19 June 2009 at the General Assembly Meeting. More information will be provided by the Director General in the coming days.
EORTC Imaging Initiative
The EORTC is currently addressing methodologies to optimally adapt cancer clinical research to embrace advances in molecular biology, and it has recently initiated the development of a clinical trial imaging platform.
